FAQ Video Library

New Effective Targets

Sunil Verma, MD, MSEd, FRCPC discusses new classes of therapies for HR+ Breast Cancer.

Sunil Verma, MD, MSEd, FRCPC
Video Categories: ESMO 2016

The Variability of HR+ Breast Cancer

Sunil Verma, MD, MSEd, FRCPC discusses treatment options for this type of cancer.

Sunil Verma, MD, MSEd, FRCPC
Video Categories: ESMO 2016

Patient Preferences

Sunil Verma, MD, MSEd, FRCPC takes up the topic of communicating with patients about what they want for their care.

Sunil Verma, MD, MSEd, FRCPC
Video Categories: ESMO 2016

Clinical Management for Relapsing Patients

Sunil Verma, MD, MSEd, FRCPC discusses all the patient factors when managing patients who relapse.

Sunil Verma, MD, MSEd, FRCPC
Video Categories: ESMO 2016

Impact of the FALCON Study

Dr Sunil Verma comments on the results of the FALCON study and how to use the data in a practical fashion to help treat patients.

Sunil Verma, MD, MSEd, FRCPC
Video Categories: ESMO 2016

Immunotherapy’s Role in Treating Hormone Receptor–Positive Diseases

Dr Thomas Bachelot discusses the potential for incorporating immunotherapy into the treatment of patients with hormone receptor–positive diseases but notes that the current data are weak, and further studies are needed to get a better sense of the viability of this treatment option.

Thomas Bachelot, MD, PhD
Video Categories: ESMO 2016

Exploring the Uses of Fulvestrant

Dr Sibylle Loibl explains how fulvestrant (with or without palbociclib) fits in the treatment paradigm for patients with HR+/ HER2-negative metastatic breast cancer.

Sibylle Loibl, MD
Video Categories: ESMO 2016

Common Issues in Treating Patients with HR+/ HER2-Negative Metastatic Breast Cancer

Dr Hope Rugo discusses some of the choices and challenges she’s faced with in treating patients with HR+/ HER2-negative metastatic breast cancer with the goal of helping patients live as long as possible and with the best quality of life.

Hope S. Rugo, MD
Video Categories: ESMO 2016

Tailoring Treatment Regimens for Patients with HR+/HER2-Negative Metastatic Breast Cancer

Dr Sunil Verma identifies how he makes treatment decisions for his patients, noting that he tends to use endocrine treatments instead of chemotherapy.

Sunil Verma, MD, MSEd, FRCPC
Video Categories: ESMO 2016

Targeted Therapies and their Impact on Melanoma

Dr. Steve O’Day works with melanoma and has seen great breakthroughs in targeted therapies and their impact on the disease.

Steven O’Day, MD
Video Categories: Targeted Therapies

Sign me up!
Friends link: prep4certs
070-411 Braindumps
VCP-550 Braindumps
70-483 Braindumps
HP2-K38
642-997
PK0-003
BH0-013
640-875
C4040-129
JN0-332
E20-547
70-462 Braindumps
400-101 Braindumps
070-461 Braindumps